FDA NDC Directory · JSON-LD · Markdown

OSPOMYV

NDC 83457-012 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namedenosumab
Labeler / ManufacturerCordavis Limited
Marketing categoryBiologic License Application · App BLA761392
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsDENOSUMAB (60 mg/mL)
Marketing started20251010
Package count1

External sources

Source: openFDA. Public-domain (CC0).